66 pending office actions • 36 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19314941 | A METHOD FOR PRODUCING PLANTS WITH MINIMIZED BIOMASS BYPRODUCT AND ASSOCIATED PLANTS THEREOF | The Regents of the University of California | MCWILLIAMS, KELSEY LYNN | 1663 | Final Rejection | Aug 29, 2025 |
| 18961937 | COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS BY VIRUS PARTICLES IN PLANTS | The Regents of the University of California | ROBINSON, KEITH O NEAL | 1661 | Non-Final OA | Nov 27, 2024 |
| 18927153 | APPARATUS AND METHODS FOR PLASMA ASSISTED COMBUSTION | VIELETECH INC. | MOUBRY, JAMES G | 3747 | Non-Final OA | Oct 25, 2024 |
| 18883520 | TARGETED COMPOSITIONS | Arbutus Biopharma Corporation | OLSON, ANDREA STEFFEL | 1693 | Non-Final OA | Sep 12, 2024 |
| 18724911 | METHODS FOR IMPROVING PROTEIN DELIVERY TO PLANT CELLS BY BIOLISTICS | The Regents of the University of California | SHEN, YANXIN NMN | 1663 | Non-Final OA | Jun 27, 2024 |
| 18639608 | THERAPEUTIC COMPOUNDS AND METHODS OF USE THEREOF | Regents Of The University Of Minnesota | MCDOWELL, BRIAN E | 1624 | Final Rejection | Apr 18, 2024 |
| 18634406 | SYNTHETIC GENOMIC SAFE HARBORS AND METHODS THEREOF | The Regents of the University of California | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Apr 12, 2024 |
| 18611953 | NEONATAL PNEUMOTHORAX DECOMPRESSION DEVICE | Regents Of The University Of Minnesota | WRUBLESKI, MATTHEW JAMES | 3781 | Non-Final OA | Mar 21, 2024 |
| 18593314 | CONJUGATES AND METHODS OF USE THEREOF | Regents Of The University Of Minnesota | BOWERS, ERIN M | 1653 | Non-Final OA | Mar 01, 2024 |
| 18687387 | PREPARATION METHOD FOR VENEER MANUFACTURED BOARD | Wanhua Chemical Group Co., Ltd. | PATWARDHAN, ABHISHEK A | 1746 | Non-Final OA | Feb 28, 2024 |
| 18572411 | THERAPEUTIC COMPOUNDS | Taxis Pharmaceuticals, Inc. | CHENG, KAREN | 1623 | Non-Final OA | Dec 20, 2023 |
| 18518267 | COMPOUNDS AND METHODS FOR TREATING HYPERKALEMIA | Ardelyx, Inc. | HOWELL, THEODORE R | 1628 | Non-Final OA | Nov 22, 2023 |
| 18284786 | EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING POST COVID-19 | Pantapharm AG | BANERJEE, KOYELI | 1658 | Non-Final OA | Sep 28, 2023 |
| 18372535 | CATALYSTS | The Regents of the University of California | LEAVITT, MORDECAI MIZANI | 1742 | Non-Final OA | Sep 25, 2023 |
| 18283361 | 2-AMINO-4-CARBOXAMIDE-BENZAZEPINE IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | SCHMIDT, IZABELA MARIA | 1621 | Non-Final OA | Sep 21, 2023 |
| 18550500 | ANTIVIRAL PRODRUGS OF ETV AND FORMULATIONS THEREOF | The Scripps Research Institute | DEKARSKE, MADELINE MCGUIRE | 1622 | Non-Final OA | Sep 14, 2023 |
| 18462235 | METHODS AND COMPOSITIONS FOR DELIVERING MYCOPHENOLIC ACID ACTIVE AGENTS TO NON-HUMAN MAMMALS | Okava Pharmaceuticals, Inc. | YOUNG, MICAH PAUL | 1618 | Non-Final OA | Sep 06, 2023 |
| 18279380 | METHODS OF ENHANCING ANTIBODY THERAPIES | UNIVERSITY OF IOWA RESEARCH FOUNDATION | ALSOMAIRY, SARAH ABDOALATIF | 1646 | Non-Final OA | Aug 29, 2023 |
| 18278904 | COMPOUNDS AND METHODS FOR TREATING CONGENITAL ERYTHROPOIETIC PORPHYRIA | Regents of the University of Michigan | PIHONAK, SARAH | 1627 | Non-Final OA | Aug 25, 2023 |
| 18237360 | METALLOENZYME MODULATORS | Regents Of The University Of Minnesota | PIHONAK, SARAH | 1627 | Non-Final OA | Aug 23, 2023 |
| 18277444 | ARTIFICIAL DNA REPLISOME AND METHODS OF USE THEREOF | Regents Of The University Of Minnesota | FRONDA, CHRISTIAN L | 1652 | Non-Final OA | Aug 16, 2023 |
| 18546217 | SMALL MOLECULE ACTIVATORS OF YAP TRANSCRIPTIONAL ACTIVITY FOR REGENERATIVE ORGAN REPAIR | The Scripps Research Institute | BRAUN, MADELINE E | 1624 | Non-Final OA | Aug 11, 2023 |
| 18276424 | BACTERIOPHAGE LYSINE, CHIMERA THEREOF AND APPLICATION THEREOF | Wuhan Lysigen Bio-Tech Company Limited | BOWERS, ERIN M | 1653 | Non-Final OA | Aug 08, 2023 |
| 18274863 | A PROCESS FOR PREPARING A VEGAN EDIBLE PRODUCT FROM EDIBLE NON-ANIMAL PROTEINS | BK Giulini GmbH | GWARTNEY, ELIZABETH A | 1759 | Non-Final OA | Jul 28, 2023 |
| 18274649 | Surface Modified Red Blood Cells And Methods Of Generating The Same | City University Of Hong Kong | KELLY, ROBERT M | 1638 | Non-Final OA | Jul 27, 2023 |
| 18274412 | INHIBITION OF DEGRANULATION OF NEUTROPHIL CELLS IN COVID-19 PATIENTS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | BANERJEE, KOYELI | 1658 | Non-Final OA | Jul 26, 2023 |
| 18261467 | SMALL MOLECULE REGULATORS OF ALVEOLAR TYPE 2 CELL PROLIFERATION FOR THE TREATMENT OF PULMONARY DISEASES | The Scripps Research Institute | PIHONAK, SARAH | 1627 | Non-Final OA | Jul 13, 2023 |
| 18216497 | THERAPEUTIC COMPOUNDS AND METHODS | Moffitt Cancer Center | HAVLIN, ROBERT H | 1626 | Non-Final OA | Jun 29, 2023 |
| 18332851 | PROTEASE INHIBITORS FOR TREATMENT OF CORONAVIRUS INFECTIONS | The Scripps Research Institute | ENGLISH, CONNOR KENNEDY | 1625 | Non-Final OA | Jun 12, 2023 |
| 18256680 | A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN | The Scripps Research Institute | SEAMAN, D MARGARET M | 1625 | Final Rejection | Jun 09, 2023 |
| 18038904 | ANTI-CEA IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | VAJDA, KRISTIN ANN | 1622 | Non-Final OA | May 25, 2023 |
| 18038897 | ANTI-HER2 IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | STOCKTON, LAURA LYNNE | 1626 | Non-Final OA | May 25, 2023 |
| 18036770 | COMPOSITIONS FOR COATING CHOCOLATE | Masterol Foods Pty. Ltd. | BEKKER, KELLY JO | 1792 | Final Rejection | May 12, 2023 |
| 18141728 | MASKED SINGLE-DOMAIN ANTIBODIES AND METHODS THEREOF | Regents Of The University Of Minnesota | TAYLOR, LIA ELAN | 1641 | Non-Final OA | May 01, 2023 |
| 18034603 | DESIGN METHODS AND MOTION CONTROL ALGORITHMS FOR IMPACT-RESILIENT MOBILE ROBOTS | The Regents of the University of California | MUELLER, SARAH ALEXANDRA | 3669 | Non-Final OA | Apr 28, 2023 |
| 18132215 | INTESTINAL EPITHELIAL CELL CULTURES | Ardelyx, Inc. | NICOL, ALEXANDER W | 1634 | Non-Final OA | Apr 07, 2023 |
| 18247616 | A DNA Assembly Mix And Method Of Uses Thereof | National University Of Singapore | TSAY, MARSHA M | 1656 | Non-Final OA | Mar 31, 2023 |
| 18022644 | CHEMICAL PROBES AND INHIBITORS FOR POLYPEPTIDES OF SARS CORONAVIRUSES | UNIVERSITÄT KONSTANZ | ROZOF, TIMOTHY R | 1625 | Non-Final OA | Feb 22, 2023 |
| 18110292 | METHOD FOR PREPARING ACTIVATED CARBON | The Regents of the University of California | MENON, KRISHNAN S | 1777 | Final Rejection | Feb 15, 2023 |
| 18017541 | PYRAZOLOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | DAHLIN, HEATHER RAQUEL | 1629 | Non-Final OA | Jan 23, 2023 |
| 18085880 | MECHANOCHEMICAL OXIDATION METHOD | UNIVERSITY OF IOWA RESEARCH FOUNDATION | FIORITO, JAMES A | 1731 | Final Rejection | Dec 21, 2022 |
| 18008391 | IDENTIFICATION OF LOW-DENSITY INFLAMMATORY NEUTROPHILS IN SEVERE COVID-19 PATIENTS | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. | WANG, RUIXUE | 1672 | Non-Final OA | Dec 05, 2022 |
| 17928535 | METHOD FOR PROVIDING CORROSION PROTECTION TO A PRESSURIZED WATER-STEAM SYSTEM | Kurita Water Industries Ltd. | DIAZ, MATTHEW R | 1761 | Non-Final OA | Nov 29, 2022 |
| 18071353 | THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B | Arbutus Biopharma Corporation | WHITEMAN, BRIAN A | 1636 | Final Rejection | Nov 29, 2022 |
| 18070288 | CHLOROPLAST TARGETING PEPTIDES AND CONJUGATES AND COMPOSITIONS THEREOF | The Regents of the University of California | SPEED, DEQUANTARIUS JAVON | 1663 | Non-Final OA | Nov 28, 2022 |
| 17925551 | RECOMBINANT PROTEINS BASED ON FIBRINOGEN | Sartorius Lab Instruments GmbH & Co. Kg | KATAKAM, SUDHAKAR | 1658 | Final Rejection | Nov 15, 2022 |
| 17923541 | ELASTASE-SUBSTRATE, PEPTIDE LINKER IMMUNOCONJUGATES, AND USES THEREOF | BOLT BIOTHERAPEUTICS, INC. | BEANE, RANDALL L | 1654 | Non-Final OA | Nov 04, 2022 |
| 17920231 | EPHA4 TARGETING COMPOUNDS AND METHODS OF USE THEREOF | Research Institute AT Nationwide Children'S Hospital | BOWLES, DAVID PAUL | 1654 | Non-Final OA | Oct 20, 2022 |
| 17954097 | ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE | European Molecular Biology Laboratory | CHOWDHURY, IQBAL HOSSAIN | 1656 | Non-Final OA | Sep 27, 2022 |
| 17910657 | SUNFLOWER PHOSPHOLIPID COMPOSITION CONTAINING PHOSPHATIDYLCHOLINE | Lipoid GmbH | ZILBERING, ASSAF | 1792 | Non-Final OA | Sep 09, 2022 |
| 17801684 | EPI-X4 BASED PEPTIDES AND DERIVATIVES THEREOF | UNIVERSITAET DUISBURG-ESSEN | MIKNIS, ZACHARY J | 1658 | Non-Final OA | Aug 23, 2022 |
| 17800806 | ARCHAEAL PYRROLYSYL TRNA SYNTHETASES FOR ORTHOGONAL USE | European Molecular Biology Laboratory | MEYERING, SHABANA SHABBEER | 1635 | Non-Final OA | Aug 18, 2022 |
| 17797644 | METHODS FOR THE TREATMENT OF HUNTER SYNDROME | Denali Therapeutics Inc. | CHANDRA, GYAN | 1674 | Non-Final OA | Aug 04, 2022 |
| 17794527 | CITRUS HUANGLONGBING THERAPEUTIC COMPOUNDS | Point Loma Nazarene University | ARMSTRONG, SUSANNAH SIPPLE | 1616 | Non-Final OA | Jul 21, 2022 |
| 17787089 | SYNTHETIC PROCESSES AND INTERMEDIATES | Arbutus Biopharma Corporation | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Jun 17, 2022 |
| 17784879 | ABS RUBBER POWDER WITH LOW IMPURITY CONTENT, PREPARATION METHOD THEREFOR, AND ABS RESIN | Wanhua Chemical Group Co., Ltd. | BLAND, ALICIA | 1759 | Final Rejection | Jun 13, 2022 |
| 17778069 | MERGING C(sp3)-H ACTIVATION WITH DNA-ENCODING | The Scripps Research Institute | FLINDERS, JEREMY C | 1684 | Final Rejection | May 19, 2022 |
| 17776428 | PHARMACEUTICAL COMPOSITION OF (S)-KETOROLAC AND PREPARATION METHOD THEREFOR | Nanjing Heron Pharmaceutical Science And Technology Co., Ltd. | KENYON, JOHN S | 1625 | Final Rejection | May 12, 2022 |
| 17640215 | DUST BINDING AGENT FOR FERTILIZER | K+S Aktiengesellschaft | SMITH, JENNIFER A | 1731 | Non-Final OA | Mar 03, 2022 |
| 17625020 | POTENTIATION OF ANTIVIRAL NUCLEOBASES AS RNA VIRUS THERAPY | Regents Of The University Of Minnesota | LEE, HOI YAN NMN | 1693 | Non-Final OA | Jan 05, 2022 |
| 17618118 | SWELL 1 MODULATORS FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, IMMUNE DEFICIENCIES, MALE INFERTILITY AND VASCULAR DISEASES | UNIVERSITY OF IOWA RESEARCH FOUNDATION | GONZALEZ, LUISALBERTO | 1624 | Final Rejection | Dec 10, 2021 |
| 17533991 | HYDROGEL-BASED 3D CELL TRAINING BIOREACTOR | The Chinese University of Hong Kong | HURST, JONATHAN M | 1799 | Non-Final OA | Nov 23, 2021 |
| 17507752 | CASCADED TYPE II SUPERLATTICE INFRARED DETECTOR OPERATING AT 300 K | Firefly Photonics, LLC | BAUMAN, SCOTT E | 2815 | Non-Final OA | Oct 21, 2021 |
| 17604314 | BIOMARKER FOR TRANSPLANTATION TOLERANCE INDUCED BY APOPTOTIC DONOR LEUKOCYTES | Regents Of The University Of Minnesota | SODERQUIST, ARLEN | 1797 | Final Rejection | Oct 15, 2021 |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | Denali Therapeutics Inc. | AEDER, SEAN E | 1642 | Non-Final OA | May 24, 2021 |
| 16972958 | CORE-SHELL IRON OXIDE-POLYMER NANOFIBER COMPOSITES FOR REMOVAL OF HEAVY METALS FROM DRINKING WATER | UNIVERSITY OF IOWA RESEARCH FOUNDATION | ROYCE, LIAM A | 1777 | Final Rejection | Dec 07, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial